Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Fareed

Showing results (101-110 of 393) with videos related to

Pageof 40
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 9, 2014
Restoration of Normal Prothrombin Time/International Normalized Ratio With Fresh Frozen Plasma in Hypocoagulable PatientsArthur J Only, Phillip J DeChristopher, Omer Iqal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 12, 2023
Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory BiomarkersPavel Poredoš, Peter Poredoš, Matija Cevc, et al.
Journal of Personalized Medicine|December 27, 2022
Cardiolipin Antibody: A Potential Biomarker for DepressionRenzo Costa, Evangelia Fatourou, Debra Hoppensteadt, et al.
Methods in Molecular Medicine|January 22, 2004
Factor Xa inhibitorsJeanine M Walenga, Walter P Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 11, 2015
Immunoenzymatic and biochip array profiling of the biomarkers of inflammation and hemostatic activation processes in ESRDJjais Richards, Vinod Bansal, Omer Iqbal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 4, 2023
The Bone Cement Hypercoagulation Syndrome: Pathophysiology, Mortality, and PreventionOla E Dahl, Are Hugo Pripp, Mark Jaradeh, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 2, 2009
Comparison of immunogenic potentials of bovine thrombin preparationsHe Zhu, Debra Hoppensteadt, Cafer Adiguzel, et al.
Future Cardiology|October 7, 2009
Update on the clinical applications of argatrobanJawed Fareed, Walter P Jeske, Debra A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Laboratory analysis of blood samples from patients treated with tinzaparinDebra A Hoppensteadt, Louise Willows, Helen Leitz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2006
Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfateJyothi Maddineni, Debra A Hoppensteadt, Umberto Cornelli, et al.
Pageof 40

Showing results (101-110 of 393) with videos related to

Sort By:
Pageof 40
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 9, 2014
Restoration of Normal Prothrombin Time/International Normalized Ratio With Fresh Frozen Plasma in Hypocoagulable PatientsArthur J Only, Phillip J DeChristopher, Omer Iqal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 12, 2023
Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory BiomarkersPavel Poredoš, Peter Poredoš, Matija Cevc, et al.
Journal of Personalized Medicine|December 27, 2022
Cardiolipin Antibody: A Potential Biomarker for DepressionRenzo Costa, Evangelia Fatourou, Debra Hoppensteadt, et al.
Methods in Molecular Medicine|January 22, 2004
Factor Xa inhibitorsJeanine M Walenga, Walter P Jeske, Debra Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 11, 2015
Immunoenzymatic and biochip array profiling of the biomarkers of inflammation and hemostatic activation processes in ESRDJjais Richards, Vinod Bansal, Omer Iqbal, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 4, 2023
The Bone Cement Hypercoagulation Syndrome: Pathophysiology, Mortality, and PreventionOla E Dahl, Are Hugo Pripp, Mark Jaradeh, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 2, 2009
Comparison of immunogenic potentials of bovine thrombin preparationsHe Zhu, Debra Hoppensteadt, Cafer Adiguzel, et al.
Future Cardiology|October 7, 2009
Update on the clinical applications of argatrobanJawed Fareed, Walter P Jeske, Debra A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|April 16, 2004
Laboratory analysis of blood samples from patients treated with tinzaparinDebra A Hoppensteadt, Louise Willows, Helen Leitz, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 14, 2006
Relative neutralization of the biological actions of sulfaminoheparosans (K5 derivatives) and heparins by protamine sulfateJyothi Maddineni, Debra A Hoppensteadt, Umberto Cornelli, et al.
Pageof 40